CK Life Sciences Intl (Holdings) Inc

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 1 security · may seek to influence control
TransCode Therapeutics, Inc. 13D/A RNAZ · 89357L501	RNAZ	89357L501	83.9%	14,134,481	13D/A	8/3/2026 Event 8/3/2026
Defj, LLC			83.9%	14,134,481
CK Life Sciences Int'l., (Holdings) Inc.			83.9%	14,134,481

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.